© Reuters. FILE PHOTO: The company logo for Oracle Corp. is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., September 18, 2019. REUTERS/Brendan McDermid
BRUSSELS (Reuters) – EU antitrust regulators are set to approve without conditions U.S. business software maker Oracle Corp (NYSE:)’s $28.3 billion acquisition of U.S. healthcare IT company Cerner Corp (NASDAQ:), people familiar with the matter said on Tuesday.
Oracle announced the deal, its biggest ever, in December last year which will give it access to a trove of data and could attract more healthcare clients to its cloud platform.
Be the first to comment